Featured Jobs
|
Anchor 3(16) Fiduciary Solutions
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Compass
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
DC Retirement Plan Administrator Michigan Pension & Actuarial Services, LLC
|
|
July Business Services
|
|
Retirement Plan Consultants
|
|
Strongpoint Partners
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Mergers & Acquisition Specialist Compass
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
|
Mercer and ERIC Comment Letter to CMS on Reporting on Pharmacy Benefits and Prescription Drug Costs (PDF)
The ERISA Industry Committee [ERIC] and Mercer
[Opinion] Feb. 1, 2022 "Some employer-sponsored medical benefits (such as expatriate plans, standalone telehealth plans, and other unique benefit designs) provide insignificant coverage of prescription drugs. Requiring these plans to report prescription drug information would be statistically inconsequential and would not benefit the Departments.... Currently, there are many programs offered to employers called copay maximizer and accumulator programs that allow the value of these programs to be captured by plan sponsors.... The Departments' approach excludes this type of cost-sharing assistance from the definition of 'prescription drug rebates, fees and other remuneration.' " MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |